These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 32666003)
1. Letter to the editor: Questioning the evidence behind the Saturation Model for testosterone replacement therapy in prostate cancer. Morgentaler A; Traish AM Investig Clin Urol; 2020 Jul; 61(4):452-454. PubMed ID: 32666003 [No Abstract] [Full Text] [Related]
2. Questioning the evidence behind the Saturation Model for testosterone replacement therapy in prostate cancer. Kim JW Investig Clin Urol; 2020 May; 61(3):242-249. PubMed ID: 32377599 [TBL] [Abstract][Full Text] [Related]
3. Re: Use of testosterone replacement therapy in the United States and its effect on subsequent prostate cancer outcomes. Taneja SS J Urol; 2013 Oct; 190(4):1246. PubMed ID: 24029310 [No Abstract] [Full Text] [Related]
4. Testosterone replacement therapy in prostate cancer patients: is it safe? Umbas R; Sugiono M Acta Med Indones; 2010 Jul; 42(3):171-5. PubMed ID: 20724773 [TBL] [Abstract][Full Text] [Related]
5. Testosterone therapy and prostate cancer--safety concerns are well founded. Klotz L Nat Rev Urol; 2015 Jan; 12(1):48-54. PubMed ID: 25563848 [TBL] [Abstract][Full Text] [Related]
6. Re: Testosterone replacement therapy in men with prostate cancer: a time-varying analysis. Seftel AD J Urol; 2015 Jun; 193(6):1985-6. PubMed ID: 25986797 [No Abstract] [Full Text] [Related]
7. Androgens and depression: a review and update. Nead KT Curr Opin Endocrinol Diabetes Obes; 2019 Jun; 26(3):175-179. PubMed ID: 30958398 [TBL] [Abstract][Full Text] [Related]
8. Use of testosterone replacement therapy in the United States and its effect on subsequent prostate cancer outcomes. Kaplan AL; Hu JC Urology; 2013 Aug; 82(2):321-6. PubMed ID: 23706552 [TBL] [Abstract][Full Text] [Related]
9. The effect of androgen supplementation therapy on the prostate. Kaufman JM Aging Male; 2003 Sep; 6(3):166-74. PubMed ID: 14628497 [TBL] [Abstract][Full Text] [Related]
10. Testosterone Therapy Can be Given to Men with No Concern that it will Promote Prostate Cancer Development or Progression: Pro. Morgentaler A J Urol; 2016 Oct; 196(4):985-8. PubMed ID: 27449261 [No Abstract] [Full Text] [Related]
11. [Prostate carcinoma and testosterone: risks and controversies]. Rhoden EL; Averbeck MA Arq Bras Endocrinol Metabol; 2009 Nov; 53(8):956-62. PubMed ID: 20126847 [TBL] [Abstract][Full Text] [Related]
12. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy. Coward RM; Simhan J; Carson CC BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450 [TBL] [Abstract][Full Text] [Related]
14. Of fires and frying pans. Roth RB; Hess E; Kaminsky AF JAMA; 2015 Feb; 313(6):632. PubMed ID: 25668278 [No Abstract] [Full Text] [Related]
15. FPIN's clinical inquiries. Testosterone therapy and risk recurrence after treatment of prostate cancer. Meza J; Weaver K; Martin S Am Fam Physician; 2013 Oct; 88(8):Online. PubMed ID: 24364582 [No Abstract] [Full Text] [Related]
16. Testosterone replacement therapy and prostate cancer: a word of caution. Brand TC; Canby-Hagino E; Thompson IM Curr Urol Rep; 2007 May; 8(3):185-9. PubMed ID: 17459266 [TBL] [Abstract][Full Text] [Related]